FDA official logo
GSRS logoPFDA official logo

TOMARALIMAB

UNII:P45C2W27DU
Formula:
Preferred Substance Name:TOMARALIMAB
GSRS Full Record:
P45C2W27DU
i

  • 1449294-76-1
  • ANTI-TLR2 MONOCLONAL ANTIBODY OPN-305
  • HUMANIZED IGG4 MONOCLONAL ANTIBODY AGAINST TOLL-LIKE RECEPTOR 2 FOR PREVENTION OF ISCHEMIA/REPERFUSION TISSUE INJURY
  • IMMUNOGLOBULIN G4, ANTI-(HUMAN TOLL-LIKE RECEPTOR TLR-2) (HUMAN-MUS MUSCULUS MONOCLONAL OPN-305 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL OPN-305 LIGHT CHAIN, DIMER
  • IMMUNOGLOBULIN G4-KAPPA, ANTI-( HOMO SAPIENS TOLL-LIKE RECEPTOR 2 (CD282 ANTIGEN))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-445) (MUS MUSCULUS VH (IGHV1-85*01 (82%) (IGHD)-IGHJ4*01 (86%)) (8.8.11) (1-118)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(226))) (119-445)) (132-218')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-218') (MUS MUSCULUS V-KAPPA (IGKV3-1*01 (82%) IGKJ1*01 (92%)(10.3.9) (1'-111')-HOMO SAPIENS IGKC*01 (112'-218')), DIMER (224-224'':227-227'')-BISDISULFIDE
  • IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TLR2 (TOLL LIKE RECEPTOR 2, TOLL-LIKE RECEPTOR 2, TIL4, CD282)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-445) (VH (MUS MUSCULUS IGHV1-85*01 (80.6%)-(IGHD)-IGHJ4*01 (85.7%)/HOMO SAPIENS IGHV1-8*03 (73.5%)-(IGHD)-IGHJ6*01 (85.7%)) (8.8.11) (1-118)-HOMO SAPIENS IGHG4*01 (CH1 (119-216), HINGE S10>P (226) (217-228), CH2 (229-338), CH3 (339-443), CHS (444-445)) (118-445)), (132-218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') (V-KAPPA (MUS MUSCULUS IGKV3-1*01 (81.8%)-IGKJ1*01 (91.7%)/HOMO SAPIENS IGKV3D-11*02 (70.2%)-(IGHD)-IGKJ4*01 (100%)) (10.3.9) (1'-111')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (157), V101 (195) (112'-218'))DIMER (224-224'':227-227'')-BISDISULFIDE
  • OPN-305
  • TOMARALIMAB [INN]
  • TOMARALIMAB [USAN]
  • TOMARALIMAB [WHO-DD]




UNII - P45C2W27DU | UNII Search Service